IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 11.08
-0.42 (-3.69%)
Jan 22, 2026, 11:01 AM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 10.66 million as of January 22, 2026. Its market cap has decreased by -2.13% in one year.
Market Cap
10.66M
Enterprise Value
7.30M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.08
Market Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 10.66M, an increase of 20.80%. That is a compound annual growth rate of 1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 10.66M | -2.13% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.41B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |